Systems medicine and artificial intelligence in retinal disease

Open Access funding enabled and organized by Projekt DEAL. OZ: Consultancy: Bayer, Novartis, Allergan, Omeicos, Oxular, SamChungDan Pharma and Boehringer Ingelheim; Grant-Support: Bayer, Novartis, Boehringer Ingelheim; Speaker honorarium: Allergan, Bayer, Novartis, Roche.

SS: Consultancy: Bayer, Novartis, Allergan, Boehringer Ingelheim, Roche, Optos, Apellis, Opthea, Oxurion; Grant-Support: Bayer, Novartis, Boehringer Ingelheim.

AJ: Consultancy: Bayer, Novartis, Roche. Grant-Support: Bayer, Novartis, Boehringer Ingelheim.

AG: Grants — Alcon, Bausch&Lomb, Zeiss, Teleon, J&J, CooperVision, Hoya. Lectures: Thea, Polpharma, Viatris. Member of Advisory Boards: Nevakar, GoCheckKids and Thea.

留言 (0)

沒有登入
gif